Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 8NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Pain 1Neoplasm Metastasis 1Humoral Hypercalcemia Of Malignancy 1

Interventions

Radiotherapy 5Analgesia 4Zoledronic Acid 2strontium chloride 1Vitamin D 1Therapeutics 1Strontium-89 1Samarium-153 1Radiosurgery 1Radiofrequency Ablation 1Psychiatric Rehabilitation 1Prednisone 1Palliative Care 1Observation 1Nutritional Support 1Neck Dissection 1Morphine 1Mitoxantrone 1Methadone 1Mental Status and Dementia Tests 1Interviews as Topic 1Ibandronic Acid 1Glutamine 1Gemcitabine 1Fibroblast Growth Factor 7 1Fatty Acids, Omega-3 1Duloxetine Hydrochloride 1Dextromethorphan 1Counseling 1Clodronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Pain × Ibandronic Acid × Clear all
NCT00301886 2013-11-13

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone

SWOG Cancer Research Network

Phase 3 Withdrawn
Breast

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡